Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » lymphoma

lymphoma

Aug 07, 2012

Cancer Genetics to Launch Two New Oncology-Focused CGH Array Tests by Year End

Premium

CHICAGO — Cancer Genetics will later this year expand its menu of array-based tests to include assays for informing treatment of patients with diffuse large B-cell lymphoma and renal cell carcinoma.

Jul 02, 2012

NCI Seeks Genomic, Proteomic Markers for Hematopoietic Malignancies

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund researchers seeking to develop and validate biomarkers that can be used to detect and predict progression of hematopoietic malignancies, such as Hodgkin and non-Hodgkin lymphoma, leukemia, multiple myeloma, and others.

May 09, 2012

MDx/CDx Focus: AssureRx Launches ADHD PGx Test; Adcetris Phase III Study in CD-30 Lymphoma; CardioDx

Premium

AssureRx Launches GeneSightRx ADHD
AssureRx Health this week launched a pharmacogenetic test, called GeneSightRx ADHD, for characterizing patients' response to a variety of attention deficit hyperactivity disorder drugs.

May 03, 2012

Mirna Reports on Role of miR-34a in B Cell Lymphoma, Expands Planned Phase I Beyond Liver Cancer

Premium

Mirna Therapeutics and collaborators at the University of Zurich reported last week that the company's therapeutic microRNA-34a mimic, dubbed MRX34, could inhibit tumor growth in an animal model of lymphoma, expanding the potential use of the agent to new cancer types.

Apr 12, 2012

Ventana Developing CDx for Seattle Genetics, Millenium Cancer Drug

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Ventana is developing a companion diagnostic test for an oncology drug developed by Seattle Genetics and Millennium Pharmaceuticals under a deal announced today.

Apr 11, 2012

HTG, Sanofi Collaborating to Identify B-Cell Response Markers for Cancer Drug

Premium

Originally published April 9.
By Turna Ray

Mar 30, 2012

Kyowa CDx Tests Approved by Regulators in Japan

By a GenomeWeb staff reporter

Mar 22, 2012

Danish Team Developing miRNA Signatures to Diagnose Skin Diseases

Premium

By Molika Ashford

Oct 14, 2011

Stanford Scientists Using Phosphoprotein Profiling to Predict Oncogene Addiction, Drug Response

Premium

By Adam Bonislawski
A team led by Stanford University researchers has developed a method for predicting response to cancer therapies based on cellular signaling protein dynamics and changes in tumor size.

Jul 25, 2011

Researchers Detect Variants Tied to Second Cancer after Hodgkin's Treatment in Childhood

Through a genome-wide association study involving hundreds of individuals treated for Hodgkin's disease as children, researchers have identified a pair of variants near the PRDM1 gene that increase the risk of a radiation-related second cancer following this treatment.

Pages

The Scan

Genomics to Trace, Prevent

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Sense of Scope in San Diego

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Boost to Wolf Diversity

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

Science Papers Present Algorithm to Diagnose Slowly Progressing Diseases, Korean Genome Project

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.